3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pancreatic Neoplasms
58
Carcinoma, Non-Small-Cell Lung
34
Urinary Bladder Neoplasms
29
Neoplasm Metastasis
20
Lung Neoplasms
19
Ovarian Neoplasms
18
Lymphoma, Large B-Cell, Diffuse
18
Cholangiocarcinoma
16
Biliary Tract Neoplasms
14
Triple Negative Breast Neoplasms
13
Neoplasms
13
Nasopharyngeal Carcinoma
13
Colorectal Neoplasms
12
Breast Neoplasms
12
Carcinoma, Transitional Cell
11
Non-Muscle Invasive Bladder Neoplasms
10
Recurrence
9
Fallopian Tube Neoplasms
9
Gallbladder Neoplasms
8
Sarcoma
6
Parkinson Disease 4, Autosomal Dominant Lewy Body
6
Bile Duct Neoplasms
6
Osteosarcoma
5
Lymphoma, Non-Hodgkin
5
Lymphoma
5
Endometrial Neoplasms
5
Uterine Cervical Neoplasms
4
Melanoma
4
Lymphoma, T-Cell, Peripheral
4
Hodgkin Disease
4
Interventions
Cyclophosphamide
13
Vincristine
10
Etoposide
8
Methotrexate
7
Doxorubicin
7
Dexamethasone
7
Cytarabine
7
venetoclax
6
Calcium Dobesilate
6
merphos
5
dexamethasone acetate
5
dexamethasone 21-phosphate
5
calaspargase pegol
5
auricularum
5
Specimen Handling
5
Prednisone
5
prednylidene
4
pegaspargase
4
deltacortene
4
Thioguanine
4
Mercaptopurine
4
Magnetic Resonance Spectroscopy
4
Leucovorin
4
Granulocyte Colony-Stimulating Factor
4
Daunorubicin
4
Asparaginase
4
fludarabine phosphate
3
daratumumab
3
azathiopurine
3
Rituximab
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
×
Gemcitabine
×
90 days
×
Clear all
No trials found.